Mariana Andrade-Medina
Research Subjects
Mariana Andrade-Medina has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Herrera-Rodulfo
Laboratorio de la Diversidad Biomolecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Unidad Monterrey, Apodaca, 66600, Nuevo León, Mexico
2 shared publications - Mauricio Carrillo-Tripp
Laboratorio Nacional de Genómica para la Biodiversidad, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Unidad Irapuato, km 9.6 Libramiento Norte, Carretera Irapuato-León, Irapuato, Guanajuato 36821, México
2 shared publications - Alberto Camacho-Morales
Department of Biochemistry and Molecular Medicine, College of Medicine, Universidad Autónoma de Nuevo León, Mexico
1 shared publication - Erandi Escamilla-García
Instituto de Biotecnología
1 shared publication - Fernando Góngora-Rivera
Neurology Department, University Hospital José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico (F.G.-R.).
1 shared publication - Juan Luis Morales-Landa
Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Subsede Noreste, vía de la Innovación 404, Parque PIIT, Apodaca 66628, Nuevo León, Mexico
1 shared publication
Latest Publications
- 11 July 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (07) , 1033-1051
Extensive In-silico Target-Ligand Conformational Space Sampling of Garlic-Derived Sulfur Compounds Targeting COVID-19 Infection
The still ongoing search for effective antiviral agents against SARS-CoV-2 has led researchers to explore natural products for potential therapeutic candidates. In this work, we conducted a comprehensive high-throughput virtual screening and molecular docking analysis of twenty-six garlic-derived sulfur-containing compounds against several key viral and host targets selected because of their relevance in the SARS-CoV-2 infection cycle. We studied the binding interactions of these compounds with targets including the viral Spike complex, Mpro and PLpro and cell’s ACE2, TMPRSS2 and Cathepsin B. Our analysis revealed that compounds [ ]-glutamyl-S-t-1-propenylcysteine, [ ]-glutamyl-S-allylcysteine, cycloalliin and carvone, exhibited the most promising binding affinities, hence act as potential inhibitors by interfering the viral entry and replication processes. Notably, they also demonstrated strong binding at the RBD-ACE2 interface, suggesting their capacity to block the initial viral attachment and entry. These findings highlight the potential of garlic-derived compounds as multi-target antiviral agents, warranting further experimental validation to confirm their efficacy and explore their therapeutic potential against COVID-19.
- 11 July 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (07) , 1033-1051
Extensive In-silico Target-Ligand Conformational Space Sampling of Garlic-Derived Sulfur Compounds Targeting COVID-19 Infection
The still ongoing search for effective antiviral agents against SARS-CoV-2 has led researchers to explore natural products for potential therapeutic candidates. In this work, we conducted a comprehensive high-throughput virtual screening and molecular docking analysis of twenty-six garlic-derived sulfur-containing compounds against several key viral and host targets selected because of their relevance in the SARS-CoV-2 infection cycle. We studied the binding interactions of these compounds with targets including the viral Spike complex, Mpro and PLpro and cell’s ACE2, TMPRSS2 and Cathepsin B. Our analysis revealed that compounds [ ]-glutamyl-S-t-1-propenylcysteine, [ ]-glutamyl-S-allylcysteine, cycloalliin and carvone, exhibited the most promising binding affinities, hence act as potential inhibitors by interfering the viral entry and replication processes. Notably, they also demonstrated strong binding at the RBD-ACE2 interface, suggesting their capacity to block the initial viral attachment and entry. These findings highlight the potential of garlic-derived compounds as multi-target antiviral agents, warranting further experimental validation to confirm their efficacy and explore their therapeutic potential against COVID-19.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (2) , 109-131
Immunomodulatory Effects of Allium sativum L. and its Constituents against Viral Infections and Metabolic Diseases
Background: Allium sativum L., or garlic, is one of the most studied plants worldwide within the field of traditional medicine. Current interests lie in the potential use of garlic as a preventive measure and adjuvant treatment for viral infections, e.g., SARS-CoV-2. Even though it cannot be presented as a single treatment, its beneficial effects are beyond doubt. The World Health Organization has deemed it an essential part of any balanced diet with immunomodulatory properties. Objective: The aim of the study was to review the literature on the effects of garlic compounds and preparations on immunomodulation and viral infection management, with emphasis on SARS-CoV- -2. Method: Exhaustive literature search has been carried out on electronic databases. Conclusion: Garlic is a fundamental part of a well-balanced diet which helps maintain general good health. The reported information regarding garlic’s ability to beneficially modulate inflammation and the immune system is encouraging. Nonetheless, more efforts must be made to understand the actual medicinal properties and mechanisms of action of the compounds found in this plant to inhibit or diminish viral infections, particularly SARS-CoV-2. Based on our findings, we propose a series of innovative strategies to achieve such a challenge in the near future.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (2) , 109-131
Immunomodulatory Effects of Allium sativum L. and its Constituents against Viral Infections and Metabolic Diseases
Background: Allium sativum L., or garlic, is one of the most studied plants worldwide within the field of traditional medicine. Current interests lie in the potential use of garlic as a preventive measure and adjuvant treatment for viral infections, e.g., SARS-CoV-2. Even though it cannot be presented as a single treatment, its beneficial effects are beyond doubt. The World Health Organization has deemed it an essential part of any balanced diet with immunomodulatory properties. Objective: The aim of the study was to review the literature on the effects of garlic compounds and preparations on immunomodulation and viral infection management, with emphasis on SARS-CoV- -2. Method: Exhaustive literature search has been carried out on electronic databases. Conclusion: Garlic is a fundamental part of a well-balanced diet which helps maintain general good health. The reported information regarding garlic’s ability to beneficially modulate inflammation and the immune system is encouraging. Nonetheless, more efforts must be made to understand the actual medicinal properties and mechanisms of action of the compounds found in this plant to inhibit or diminish viral infections, particularly SARS-CoV-2. Based on our findings, we propose a series of innovative strategies to achieve such a challenge in the near future.